Endocardial Fibroelastosis as an Independent Predictor of Atrioventricular Valve Rupture in Maternal Autoimmune Antibody Exposed Fetus: A Systematic Review with Clinicopathologic Analysis.
anti La/SSB antibodies
anti-Ro/SSA antibodies
complete heart block
endocardial fibroelastosis
maternal autoantibodies
mitral valve rupture
neonatal lupus
tricuspid valve rupture
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
20 Apr 2023
20 Apr 2023
Historique:
received:
16
02
2023
revised:
12
04
2023
accepted:
13
04
2023
medline:
16
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Neonatal lupus (NL) is a clinical syndrome that develops in the fetus as a result of maternal autoimmune antibodies. Congenital complete heart block (CHB) is the most common manifestation, while extranodal cardiac manifestations of NL, such as endocardial fibroelastosis (EFE) and myocarditis, are rare but more serious. Less is known about this atrioventricular valve rupture due to valvulitis as a consequence of maternal autoantibodies. We have described a case of cardiac neonatal lupus with an antenatally detected CHB patient who developed mitral and tricuspid valve chordal rupture at 45 days of age. We compared the cardiac histopathology and the fetal cardiac echocardiographic findings of this case with another fetus that was aborted after being antenatally diagnosed with CHB but without valvar rupture. A narrative analysis after a systematic review of the literature regarding atrioventricular valve apparatus rupture due to autoimmune etiology along with maternal characteristics, presentation, treatment, and outcome have been discussed in this article. To describe published data on atrioventricular valve rupture in neonatal lupus, including clinical presentation, diagnostic evaluation, management, and outcomes. We conducted a PRISMA-compliant descriptive systematic examination of case reports that included accounts of lupus during pregnancy or in the newborn period that resulted in an atrioventricular valve rupture. We gathered information on the patient's demographics, the details of the valve rupture and other comorbidities, the maternal therapy, the clinical course, and the results. We also used a standardized method to evaluate the cases' quality. A total of 12 cases were investigated, with 11 cases drawn from 10 case reports or case series and 1 from our own experience. Tricuspid valve rupture (50%) is more common than mitral valve rupture (17%). Unlike mitral valve rupture, which occurs postnatally, the timing of tricuspid valve rupture is perinatal. A total of 33% of the patients had concomitant complete heart block, while 75% of the patients had endocardial fibroelastosis on an antenatal ultrasound. Antenatal changes pertaining to endocardial fibroelastosis can be seen as early as 19 weeks of gestation. Patients with both valve ruptures generally have a poor prognosis, especially if they occur at close intervals. Atrioventricular valve rupture in neonatal lupus is rare. A majority of patients with valve rupture had antenatally detected endocardial fibroelastosis in the valvar apparatus. Appropriate and expedited surgical repair of ruptured atrioventricular valves is feasible and has a low mortality risk. Rupture of both atrioventricular valves occurring at close intervals carries a high mortality risk.
Sections du résumé
BACKGROUND
BACKGROUND
Neonatal lupus (NL) is a clinical syndrome that develops in the fetus as a result of maternal autoimmune antibodies. Congenital complete heart block (CHB) is the most common manifestation, while extranodal cardiac manifestations of NL, such as endocardial fibroelastosis (EFE) and myocarditis, are rare but more serious. Less is known about this atrioventricular valve rupture due to valvulitis as a consequence of maternal autoantibodies. We have described a case of cardiac neonatal lupus with an antenatally detected CHB patient who developed mitral and tricuspid valve chordal rupture at 45 days of age. We compared the cardiac histopathology and the fetal cardiac echocardiographic findings of this case with another fetus that was aborted after being antenatally diagnosed with CHB but without valvar rupture. A narrative analysis after a systematic review of the literature regarding atrioventricular valve apparatus rupture due to autoimmune etiology along with maternal characteristics, presentation, treatment, and outcome have been discussed in this article.
OBJECTIVES
OBJECTIVE
To describe published data on atrioventricular valve rupture in neonatal lupus, including clinical presentation, diagnostic evaluation, management, and outcomes.
METHODS
METHODS
We conducted a PRISMA-compliant descriptive systematic examination of case reports that included accounts of lupus during pregnancy or in the newborn period that resulted in an atrioventricular valve rupture. We gathered information on the patient's demographics, the details of the valve rupture and other comorbidities, the maternal therapy, the clinical course, and the results. We also used a standardized method to evaluate the cases' quality. A total of 12 cases were investigated, with 11 cases drawn from 10 case reports or case series and 1 from our own experience.
RESULTS
RESULTS
Tricuspid valve rupture (50%) is more common than mitral valve rupture (17%). Unlike mitral valve rupture, which occurs postnatally, the timing of tricuspid valve rupture is perinatal. A total of 33% of the patients had concomitant complete heart block, while 75% of the patients had endocardial fibroelastosis on an antenatal ultrasound. Antenatal changes pertaining to endocardial fibroelastosis can be seen as early as 19 weeks of gestation. Patients with both valve ruptures generally have a poor prognosis, especially if they occur at close intervals.
CONCLUSION
CONCLUSIONS
Atrioventricular valve rupture in neonatal lupus is rare. A majority of patients with valve rupture had antenatally detected endocardial fibroelastosis in the valvar apparatus. Appropriate and expedited surgical repair of ruptured atrioventricular valves is feasible and has a low mortality risk. Rupture of both atrioventricular valves occurring at close intervals carries a high mortality risk.
Identifiants
pubmed: 37189582
pii: diagnostics13081481
doi: 10.3390/diagnostics13081481
pmc: PMC10137427
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cardiol Young. 2017 Oct;27(8):1637-1640
pubmed: 28534460
Cardiovasc Res. 2020 Jul 1;116(8):1446-1457
pubmed: 31589297
Circulation. 2011 Nov 1;124(18):1927-35
pubmed: 21969015
J Am Heart Assoc. 2022 Feb;11(3):e023000
pubmed: 35001672
Eur J Pediatr. 2009 Jun;168(6):741-3
pubmed: 18758812
Rheumatology (Oxford). 2012 Jun;51(6):1086-92
pubmed: 22308531
J Rheumatol. 2011 Feb;38(2):378-86
pubmed: 21078712
Nat Rev Rheumatol. 2015 May;11(5):301-12
pubmed: 25800217
Am J Cardiol. 2011 Mar 1;107(5):761-6
pubmed: 21247531
Circulation. 2014 Sep 23;130(13):1053-61
pubmed: 25062691
World J Pediatr Congenit Heart Surg. 2022 Mar;13(2):260-263
pubmed: 34775849
Cardiol Young. 2022 Jul;32(7):1041-1047
pubmed: 34486505
J Am Coll Cardiol. 2002 Aug 21;40(4):796-802
pubmed: 12204513
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
Ann Thorac Surg. 2007 Apr;83(4):1458-62
pubmed: 17383357
Pediatr Cardiol. 2008 Mar;29(2):442-5
pubmed: 17882476
Curr Cardiol Rep. 2020 Nov 25;23(1):3
pubmed: 33241446
Ann Thorac Surg. 2014 Sep;98(3):1098-101
pubmed: 25193198
Cardiol Young. 2017 Sep;27(7):1419-1422
pubmed: 28460654
Autoimmun Rev. 2017 Apr;16(4):427-432
pubmed: 28212920
Diagnostics (Basel). 2020 Jul 14;10(7):
pubmed: 32674462
Ann Rheum Dis. 2020 Feb;79(2):217-224
pubmed: 31672776
Australas J Ultrasound Med. 2015 Aug;18(3):124-128
pubmed: 28191254
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Pediatr Cardiol. 1994 Jul-Aug;15(4):204-6
pubmed: 7991440
Circulation. 2002 Feb 19;105(7):843-8
pubmed: 11854125
RMD Open. 2020 Jan;6(1):
pubmed: 31958275
J Am Coll Cardiol. 2020 Jul 21;76(3):292-302
pubmed: 32674792
J Am Coll Cardiol. 2002 Jan 2;39(1):130-7
pubmed: 11755298
Eur J Pediatr. 2012 Feb;171(2):259-65
pubmed: 21739172
J Matern Fetal Neonatal Med. 2009 Mar;22(3):233-8
pubmed: 19330707
J Clin Rheumatol. 2021 Dec 1;27(8):e525-e532
pubmed: 32558678